MAR trades against a final fair-value range of $151.90-$303.69, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $152, high $304, with mid-point at $228.
Currently screens above fair value, so patience matters more than entry speed.
Fair value
$228
Margin of safety
-57.4%
Confidence
88/100
Moat
9/10
Educational analysis only — not financial advice. Always do your own due diligence.
$358.69Price
Low $151.9
Mid $227.84
High $303.69
MAR trades against a final fair-value range of $151.90-$303.69, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
Dominant Bonvoy loyalty ecosystem locking
Dominant Bonvoy loyalty ecosystem locking in high-value corporate travelers.
Global scale and brand portfolio
Global scale and brand portfolio yielding immense pricing power.
Cycle upside
Global travel demand outstrips limited supply pipelines, driving aggressive ADR (Average Daily Rate) and RevPAR expansion across upscale portfolios.
Reverse DCF for MAR (MAR) backs out the revenue or earnings growth rate the current share price implies, holding terminal value, margin, and discount-rate assumptions constant.
We compare the implied rate to our own forecast deceleration curve and to the historical five-year actual. When the implied rate exceeds the realistic ceiling, the price is pricing in optimism the business has not yet demonstrated.
Reverse DCF uses cost of equity (Ke), not WACC, to stay consistent with the EPS-based forward valuation models. Ke is derived from CAPM with adjusted beta; the strict and moderate variants are documented in the assumption ledger.
When the implied growth rate is below our forecast, the market is underpricing the business; when it is above, the market is overpricing. The reverse-DCF read is one of four lenses that feed the composite fair-value range and the rating band.
FAQ
MAR — frequently asked questions
Based on our latest analysis, MAR looks meaningfully overvalued. The current price is $359 versus a composite fair-value midpoint of $228 (range $152–$304), which implies roughly 36.5% downside to the midpoint.
Our composite fair-value range for MAR is $152–$304, with a midpoint of $228. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for MAR's archetype.
Our current rating for MAR is Sell with a confidence score of 88/100. MAR is rated Sell at $358.69 versus the reconciled fair value midpoint of $227.84, implying -36.48% upside/downside. Confidence is separately disclosed at 88/100. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for MAR are: Interest Rate Shock & Refinancing Squeeze; Valuation Multiple Mean Reversion; Structural Corporate Travel Decline. The single biggest risk is The biggest risk is that the bear-case drivers materialize: growth slows, margins compress, or competitive pressure reduces the fair-value range.
Our current rating for MAR is Sell, issued with a confidence score of 88/100 and a moat score of 9/10. The rating reflects the composite fair-value range ($152–$304) versus the current price of $359.
MAR is classified as a mature compounder stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for MAR.